Topics

Articles

According to AbbVie, ImmunoGen's entire oncology portfolio could drive long-term revenue growth, giving the company a potential multi-billion dollar drug that is already on the market.

AbbVie Finalizes Deal to Acquire ImmunoGen With its Pipeline of Antibody Drug Conjugates 

Technavio analysis notes that an increase drug patent expirations could be a contributing factor. 

Forecast Predicts Generic Drug Market Will Grow Upwards of $175B Over the Next Three Years

The acquisition expands Merck’s portfolio in the veterinary pharma space. 

Merck Animal Health Inks $1.3 Billion Deal for Elanco’s Aqua Brand

The deal is expected to help boost supply of Wegovy.

Novo Nordisk’s Parent Company Purchases Catalent for $16.5 Billion

. He can be reached at nsaraceno@mjhlifesciences.com.

Pharma Commerce travels to Orlando for a pulse-check on this fast-evolving landscape in patient care.  

Access Insights and Information Abound

An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.

Who Moved My Prescription? Part II

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending. 

The Path for Prescription Drug Sales 

Leading experts in the sector explore the value of third-party logistics providers when it comes to fortifying pharmaceutical supply chains. 

Peeking Behind the Curtain: The Current State of Pharma 3PLs and Future Outlook

Health Affairs study investigates the consequences of patient medication abandonment surrounding oral HIV pre-exposure prophylaxis.

Forecasting the Effect of Out-of-Pocket Cost Changes for HIV Medication

In order to provide both profitability and medication access, a balancing act is required.

Business and Finance